SCHEMBL1904205

SCHEMBL1904205

NC(=O)[C@H](CCC(=O)O)N(C=O)OCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 3/20 0.40
LTA4H P09960 3/20 0.39
CPA3 P15088 1/20 0.39
EPOR P19235 1/20 0.38
SLC1A3 P43003 2/20 0.38
SLC1A2 P43004 2/20 0.38
SLC1A1 P43005 2/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
KMT2A Q03164 1/20 0.38
FFAR1 O14842 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37
ALOX5 P09917 1/20 0.36
KEAP1 Q14145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6955548 0.89 FOLH1 (0.46) FOLH1LTA4HCPA3EPORSLC1A3
SCHEMBL7394633 0.78 FOLH1 (0.37) FOLH1CPA3EPOR
SCHEMBL7084386 0.78 FOLH1 (0.41) FOLH1LTA4HCPA3FFAR1FFAR4
SCHEMBL7420915 0.78 SLC1A1 (0.44) SLC1A3SLC1A2SLC1A1MEN1CYP1A2
SCHEMBL6299671 0.77 ALDH1A1 (0.43) FOLH1LTA4HSLC1A3SLC1A2SLC1A1
SCHEMBL6298147 0.77 ALDH1A1 (0.43) FOLH1LTA4HSLC1A3SLC1A2SLC1A1
SCHEMBL10540689 0.76 MAPT (0.42) FOLH1LTA4HALOX5
SCHEMBL10686536 0.76 CYP1A2 (0.43) FOLH1CPA3SLC1A3SLC1A2SLC1A1
SCHEMBL16166282 0.75 SLC1A3 (0.41) SLC1A3SLC1A2SLC1A1MEN1CYP1A2
SCHEMBL7515528 0.75 SLC1A3 (0.38) FOLH1LTA4HSLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4021450-A1 METHODS OF TREATING BREAST CANCER WITH TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS Arvinas Operations, Inc. (US) 2022-07-06 EP disclosed
WO-2021041348-A1 METHODS OF TREATING BREAST CANCER WITH TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS ARVINAS OPERATIONS, INC. (US) 2021-03-04 WO disclosed
WO-2011050962-A1 ACID ADDITION SALTS OF LENALIDOMIDE RATIOPHARM GMBH (DE) 2011-05-05 WO disclosed